Karissa Cottier, PhD Research Scientist, BioIVT, ADME-Tox, examines the ongoing development and advances to ensure drug efficacy and safety Researchers evaluate the efficacy and safety profiles of drug candidates, including their potential to cause liver damage, when considering whether to advance them in development programs. Drug-induced liver injury (DILI) is a significant contributor to safety-related clinical […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!